AscellaHealth Releases Midyear Pipeline Outlook as Specialty Costs Rise
BERWYN, PA — AscellaHealth released its second-quarter 2026 Specialty & Rare Pipeline Digest, outlining how a growing pipeline of specialty drugs, cell and gene therapies, biosimilars, and treatments for metabolic …
AscellaHealth Releases Midyear Pipeline Outlook as Specialty Costs Rise Read More